My name is Inês Ramos and I work as a data analyst at the Portuguese Medicines and Health Products Authority (aka Infarmed), where I develop drug utilization studies and policies impact evaluations using primarily drug reimbursement claims .
One of my main projects at work is a study of the treatment pathways in diabetes using reimbursement claims. We hope to publish the first paper arising from this project soon.
While I was doing the bibliographic revision, I stumbled upon the paper 'Characterizing treatment pathways at scale using the OHDSI network' and thought it was an amazing endeavour. So here I am.
I am curious if we could adapt the Portuguese data to the OMOP common data model and, perhaps, participate in a future study. It would be an amazing improvement if we could benchmark the results against results from other countries.
Can you help me satisfy my curiosity?
Icons made by Portugal from www.flaticon.com is licensed by CC 3.0 BY